uitsluitend voor onderzoeksdoeleinden

Monastrol Kinesin remmer

Cat.Nr.S8439

Monastrol ((±)-Monastrol) is een celpermeabele, kleine molecuulremmer van kinesin-5(KIF11) met een IC50 van 14μM, die essentieel is voor het handhaven van de scheiding van de halve spoelfiguren.
Monastrol Kinesin remmer Chemical Structure

Chemische structuur

Moleculair gewicht: 292.35

Ga naar

Kwaliteitscontrole

Batch: Zuiverheid: 99.86%
99.86

Celkweek, behandeling & werkconcentratie

Cellijnen Assaytype Concentratie Incubatietijd Formulering Activiteitsbeschrijving PMID
HeLa Function assay 12 hrs Inhibition of Eg5 ATPase activity expressed in HeLa cells after 12 hrs, IC50=6.1μM 17587586
HCT116 Cell cycle assay Effect on cell cycle progression in human HCT116 cells assessed as mitotic arrest measured by doubling DNA content by fluorescence microscopy, EC50=1.2μM 18793847
HCT116 Cell cycle assay Effect on cell cycle progression in human HCT116 cells assessed as increase in phospho-histone H3 by fluorescence microscopy, EC50=1.5μM 18793847
KBV1/KB3-1 Function assay Drug resistant ratio of EC50 for human KBV1 cells overexpressing MDR1 to EC50 for KB3-1 cells, EC50=0.0012μM 20597485
HCT116 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT116 cells after 72 hrs by Alamar blue assay, EC50=24.155μM 20597485
hTERT-HME1 Antiproliferative assay 72 hrs Antiproliferative activity against human hTERT-HME1 cells after 72 hrs by Alamar blue assay, EC50=45.082μM 20597485
KBV1 Antiproliferative assay 72 hrs Antiproliferative activity against human KBV1 cells overexpressing MDR1 after 72 hrs by Alamar blue assay in presence of zosuquidar, EC50=45.394μM 20597485
HL-60(TB) Growth inhibition assay Growth inhibition of human HL-60(TB) cells, GI50=25.1μM 21855351
M14 Growth inhibition assay Growth inhibition of human M14 cells, GI50=25.1μM 21855351
CCRF-CEM Growth inhibition assay Growth inhibition of human CCRF-CEM cells, GI50=31.6μM 21855351
K562 Growth inhibition assay Growth inhibition of human K562 cells, GI50=31.6μM 21855351
MOLT4 Growth inhibition assay Growth inhibition of human MOLT4 cells, GI50=31.6μM 21855351
SR Growth inhibition assay Growth inhibition of human SR cells, GI50=31.6μM 21855351
NCI-H522 Growth inhibition assay Growth inhibition of human NCI-H522 cells, GI50=31.6μM 21855351
COLO205 Growth inhibition assay Growth inhibition of human COLO205 cells, GI50=31.6μM 21855351
HCT116 Growth inhibition assay Growth inhibition of human HCT116 cells, GI50=31.6μM 21855351
KM12 Growth inhibition assay Growth inhibition of human KM12 cells, GI50=31.6μM 21855351
SF295 Growth inhibition assay Growth inhibition of human SF295 cells, GI50=31.6μM 21855351
U251 Growth inhibition assay Growth inhibition of human U251 cells, GI50=31.6μM 21855351
SK-MEL-2 Growth inhibition assay Growth inhibition of human SK-MEL-2 cells, GI50=31.6μM 21855351
RPMI8266 Growth inhibition assay Growth inhibition of human RPMI8266 cells, GI50=31.6μM 21855351
NCI-H322M Growth inhibition assay Growth inhibition of human NCI-H322M cells, GI50=39.8μM 21855351
HCC2998 Growth inhibition assay Growth inhibition of human HCC2998 cells, GI50=39.8μM 21855351
HCT15 Growth inhibition assay Growth inhibition of human HCT15 cells, GI50=39.8μM 21855351
SW620 Growth inhibition assay Growth inhibition of human SW620 cells, GI50=39.8μM 21855351
SNB75 Growth inhibition assay Growth inhibition of human SNB75 cells, GI50=39.8μM 21855351
SK-MEL-5 Growth inhibition assay Growth inhibition of human SK-MEL-5 cells, GI50=39.8μM 21855351
UACC62 Growth inhibition assay Growth inhibition of human UACC62 cells, GI50=39.8μM 21855351
SN12C Growth inhibition assay Growth inhibition of human SN12C cells, GI50=39.8μM 21855351
HL-60(TB) Growth inhibition assay 24 hrs Growth inhibition of human HL-60(TB) cells incubated for 24 hrs by MTT assay, IC50=0.147μM 28667871
MOLT4 Growth inhibition assay 24 hrs Growth inhibition of human MOLT4 cells incubated for 24 hrs by MTT assay, IC50=0.215μM 28667871
TC32 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells 29435139
DAOY qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells 29435139
SJ-GBM2 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells 29435139
A673 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells 29435139
SK-N-MC qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells 29435139
NB-EBc1 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells 29435139
LAN-5 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells 29435139
BT-12 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells 29435139
OHS-50 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells 29435139
A673 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for A673 cells) 29435139
SK-N-MC qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-MC cells 29435139
TC32 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for TC32 cells 29435139
U-2 OS qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for U-2 OS cells 29435139
McCoy Cytotoxicity assay 72 hrs Cytotoxicity against mouse McCoy cells assessed as decrease in cell viability after 72 hrs by MTT assay, IC50=26.8μM 29908443
MM1S Antiproliferative assay 72 hrs Antiproliferative activity against human MM1S cells incubated for 72 hrs by MTT assay, IC50=8.7μM ChEMBL
HCT116 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT116 cells incubated for 72 hrs by MTT assay, IC50=9μM ChEMBL
C6 Antiproliferative assay 100 uM 24 hrs Antiproliferative activity against rat C6 cells assessed as reduction in cell viability at 100 uM after 24 hrs by MTS assay relative to control ChEMBL
C6 Cell cycle assay 100 uM 24 hrs Cell cycle arrest in rat C6 cells assessed as accumulation at G2/M phase at 100 uM after 24 hrs by propidium iodide staining based flow cytometry ChEMBL
U138MG Apoptosis assay 200 uM 48 hrs Induction of apoptosis in human U138MG cells at 200 uM after 48 hrs by Annexin V/propidium iodide staining based flow cytometry ChEMBL
U138MG Necrosis assay 200 uM 48 hrs Induction of necrosis in human U138MG cells at 200 uM after 48 hrs by Annexin V/propidium iodide staining based flow cytometry ChEMBL
C6 Apoptosis assay 100 uM 48 hrs Induction of apoptosis in rat C6 cells at 100 uM after 48 hrs by Annexin V/propidium iodide staining based flow cytometry ChEMBL
U138MG Function assay 200 uM 24 hrs Inhibition of EG5 in human U138MG cells assessed as monopolar spindle formation at 200 uM after 24 hrs by Hoechst staining based immunofluorescence microscopic method ChEMBL
C6 Function assay 100 uM 24 hrs Inhibition of EG5 in rat C6 cells assessed as monopolar spindle formation at 100 uM after 24 hrs by Hoechst staining based immunofluorescence microscopic method ChEMBL
C6 Antiproliferative assay 5 to 50 uM 48 hrs Antiproliferative activity against rat C6 cells at 5 to 50 uM after 48 hrs by Neubauer chamber method ChEMBL
MCF7 Antiproliferative assay 25 uM 48 hrs Antiproliferative activity against human MCF7 cells at 25 uM after 48 hrs by sulforhodamine B assay ChEMBL
NCI/ADR-RES Antiproliferative assay 25 uM 48 hrs Antiproliferative activity against human NCI/ADR-RES cells at 25 uM after 48 hrs by sulforhodamine B assay ChEMBL
786-0 Antiproliferative assay 25 uM 48 hrs Antiproliferative activity against human 786-0 cells at 25 uM after 48 hrs by sulforhodamine B assay ChEMBL
HT-29 Antiproliferative assay 25 uM 48 hrs Antiproliferative activity against human HT-29 cells at 25 uM after 48 hrs by sulforhodamine B assay ChEMBL
UACC62 Antiproliferative assay 25 uM 48 hrs Antiproliferative activity against human UACC62 cells at 25 uM after 48 hrs by sulforhodamine B assay ChEMBL
PC3 Antiproliferative assay 25 uM 48 hrs Antiproliferative activity against human PC3 cells at 25 uM after 48 hrs by sulforhodamine B assay ChEMBL
OVCAR3 Antiproliferative assay 25 uM 48 hrs Antiproliferative activity against human OVCAR3 cells at 25 uM after 48 hrs by sulforhodamine B assay ChEMBL
Klik om meer experimentele gegevens over de cellijn te bekijken

Chemische informatie, Opslag en Stabiliteit

Moleculair gewicht 292.35 Formule

C14H16N2O3S

Opslag (Vanaf de ontvangstdatum) 3 years -20°C(in the dark) powder
CAS-nr. 329689-23-8 SDF downloaden Opslag van stamoplossingen

Synoniemen (±)-Monastrol Smiles CCOC(=O)C1=C(NC(=S)NC1C2=CC(=CC=C2)O)C

Oplosbaarheid

In vitro
Batch:

DMSO : 58 mg/mL (198.39 mM)
(Met vocht verontreinigde DMSO kan de oplosbaarheid verminderen. Gebruik verse, watervrije DMSO.)

Ethanol : 58 mg/mL

Water : Insoluble

Molariteitscalculator

Massa Concentratie Volume Moleculair gewicht
Verdunningscalculator Moleculair gewicht calculator

In vivo
Batch:

In vivo Formuleringscalculator (Heldere oplossing)

Stap 1: Voer de onderstaande informatie in (Aanbevolen: Een extra dier voor het geval van verlies tijdens het experiment)

mg/kg g μL

Stap 2: Voer de in vivo formulering in (Dit is alleen de calculator, geen formulering. Neem eerst contact met ons op als er geen in vivo formulering is in het gedeelte Oplosbaarheid.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Berekeningsresultaten:

Werkconcentratie: mg/ml;

Methode voor het bereiden van DMSO-mastervloeistof: mg geneesmiddel vooraf opgelost in μL DMSO ( Concentratie mastervloeistof mg/mL, Neem eerst contact met ons op als de concentratie de DMSO-oplosbaarheid van de partij geneesmiddel overschrijdt. )

Methode voor het bereiden van in vivo formulering: Neem μL DMSO mastervloeistof, voeg vervolgens toeμL PEG300, mengen en helder maken, voeg vervolgens toeμL Tween 80, mengen en helder maken, voeg vervolgens toe μL ddH2O, mengen en helder maken.

Methode voor het bereiden van in vivo formulering: Neem μL DMSO mastervloeistof, voeg vervolgens toe μL Maïsolie, mengen en helder maken.

Opmerking: 1. Zorg ervoor dat de vloeistof helder is voordat u het volgende oplosmiddel toevoegt.
2. Zorg ervoor dat u het/de oplosmiddel(en) in de juiste volgorde toevoegt. U moet ervoor zorgen dat de verkregen oplossing, bij de vorige toevoeging, een heldere oplossing is voordat u verdergaat met het toevoegen van het volgende oplosmiddel. Fysische methoden zoals vortexen, echografie of een warmwaterbad kunnen worden gebruikt om het oplossen te bevorderen.

Werkingsmechanisme

Targets/IC50/Ki
KIF11(Eg5)
(Cell-based assay)
14 μM
In vitro

Monastrol remt de progressie door de S- en G2-fasen van de celcyclus of de centrosome-duplicatie niet. De mitotische arrestatie als gevolg van deze verbinding is ook snel omkeerbaar. Het remt ook de vorming van bipolaire spoelfiguren in Xenopus-eiextracten. Deze chemische stof arresteert cellen in mitose met monoastrale spoelfiguren bestaande uit een radiale reeks microtubuli omgeven door een ring van chromosomen, terwijl het de microtubuli in interfasecellen of microtubuli-polymerisatie in vitro niet beïnvloedt. Blootstelling van gekweekte sympathische neuronen aan deze verbinding gedurende een paar uur verhoogt zowel het aantal als de groeisnelheid van de axonen. Na extra tijd zijn de totale lengtes van de axonen niet te onderscheiden van controles. Sensorische neuronen vertonen een vergelijkbare kortetermijnstijging van de axonale groeisnelheid. Langdurige blootstelling resulteert echter in kortere axonen, wat suggereert dat sensorische neuronen gevoeliger kunnen zijn voor toxische effecten van het medicijn. Niettemin is de algehele gezondheid van de culturen nog steeds veel robuuster dan culturen behandeld met taxol, een medicijn dat vaak wordt gebruikt voor chemotherapie. In HeLa-cellen activeert deze verbinding het spoelfiguurcheckpoint, wat leidt tot mitotische arrestatie en apoptose.

Referenties
  • [4] https://pubmed.ncbi.nlm.nih.gov/10542155/

Toepassingen

Methoden Biomarkers Afbeeldingen PMID
Growth inhibition assay Cell viability
S8439-viability1
26035434
Western blot Cyclin B / Survivin
S8439-WB1
26035434

Technische ondersteuning

Gebruiksaanwijzing

Tel: +1-832-582-8158 Ext:3

Als u nog andere vragen heeft, kunt u een bericht achterlaten.

Gelieve uw naam in te voeren.
Gelieve uw e-mailadres in te voeren. Voer een geldig e-mailadres in.
Schrijf alstublieft iets voor ons.